EFDID: 295030EFD: View Filing

Issuer: Precision Therapeutics Inc. (0001446159) - D

Accession: 0001288230-18-000011 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001446159
  • Entity Name:
    Precision Therapeutics Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2013)
  • Address:
    2915 COMMERS DRIVE,
    SUITE 900
    EAGAN, MN 55121
  • Persons:
    Related Persons 7
    Carl Schwartz
    Executive Officer, Director
    J Melville Engle
    Director
    Richard L Gabriel
    Director
    Timothy A Krochuk
    Director
    Thomas McGoldrick
    Director
    Bob Myers
    Executive Officer
    Andrew Reding
    Director
EDGAR: Offering Information
  • Accession Date:
    10/11/2018
  • First Sale Date:
    09/28/2018
  • Offering Amount:
    $2,500,000
  • Amount Sold:
    $2,000,000
  • Amount Remaining:
    $500,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Debt
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:None
Inactive:PR
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
David Weinstein 130645 Dawson James Securities, Inc. 130645 FL, PR
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Precision Therapeutics Inc./s/ Bob MyersBob MyersChief Financial Officer and Secretary2018-10-11